PT Millennium Pharmacon International Tbk
IDX:SDPC.JK
143 (IDR) • At close October 30, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) IDR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 3,363,517.808 | 3,200,833.096 | 2,988,848.566 | 2,643,626.505 | 2,726,755.413 | 2,376,182.739 | 2,110,824.973 | 1,970,114.276 | 1,707,613.43 | 1,437,667.563 | 1,310,244.155 | 1,172,974.793 | 973,210.721 | 836,964.147 | 1,010,934.004 |
Kosten van de omzet
| 3,090,142.433 | 2,931,198.452 | 2,747,094.996 | 2,421,934.898 | 2,497,998.546 | 2,166,027 | 1,931,226.824 | 1,800,872.528 | 1,550,312.638 | 1,306,133.352 | 1,189,781.957 | 1,068,515.421 | 885,991.104 | 756,729.731 | 916,547.64 |
Brutowinst
| 273,375.375 | 269,634.644 | 241,753.571 | 221,691.608 | 228,756.867 | 210,155.739 | 179,598.149 | 169,241.748 | 157,300.792 | 131,534.21 | 120,462.198 | 104,459.372 | 87,219.617 | 80,234.416 | 94,386.365 |
Brutowinstmarge
| 0.081 | 0.084 | 0.081 | 0.084 | 0.084 | 0.088 | 0.085 | 0.086 | 0.092 | 0.091 | 0.092 | 0.089 | 0.09 | 0.096 | 0.093 |
Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 29,726.882 | 32,024.81 | 24,731.152 | 23,098.697 | 23,991.593 | 22,045.476 | 17,941.519 | 81,439.287 | 15,140.059 | 12,955.248 | 11,744.661 | 11,011.568 | 49,889.694 | 50,411.557 | 48,453.685 |
Verkoop- en marketingkosten
| 28,289.28 | 25,877.158 | 28,507.566 | 27,938.116 | 27,616.395 | 22,159.212 | 21,031.766 | 39,655.505 | 12,144.075 | 10,534.814 | 9,348.385 | 9,011.962 | 20,803.172 | 16,844.338 | 16,420.146 |
Verkoop-, algemene en administratieve kosten
| 170,886.12 | 57,901.968 | 53,238.718 | 51,036.813 | 51,607.988 | 44,204.688 | 38,973.285 | 121,094.792 | 27,284.134 | 23,490.062 | 21,093.046 | 20,023.53 | 70,692.866 | 67,255.895 | 64,873.831 |
Overige kosten
| -3,643.483 | 127,348.628 | 119,684.005 | 116,879.622 | 111,869.4 | 102,851.818 | 91,317.029 | 267.052 | 2,080.15 | 372.513 | 1,842.187 | 1,106.1 | -451.8 | -1,501.133 | -3,643.384 |
Bedrijfskosten
| 174,529.603 | 185,250.596 | 172,922.723 | 167,916.435 | 163,477.387 | 146,835.223 | 129,778.966 | 121,361.843 | 114,856.834 | 97,960.629 | 89,285.927 | 80,339.798 | 70,241.066 | 67,255.895 | 64,873.831 |
Bedrijfsresultaat
| 98,845.772 | 73,962.099 | 57,736.785 | 52,772.343 | 64,766.292 | 63,105.477 | 49,321.987 | 47,879.904 | 42,502.506 | 31,851.624 | 28,912.382 | 22,936.681 | 16,978.551 | 12,978.52 | 29,512.534 |
Bedrijfsresultaat ratio
| 0.029 | 0.023 | 0.019 | 0.02 | 0.024 | 0.027 | 0.023 | 0.024 | 0.025 | 0.022 | 0.022 | 0.02 | 0.017 | 0.016 | 0.029 |
Totaal overige inkomsten en kosten netto
| -50,885.004 | -37,497.965 | -39,814.268 | -45,032.967 | -52,796.809 | -34,508.313 | -28,633.522 | -30,632.375 | -25,728.767 | -21,602.75 | -13,469.741 | -9,672.908 | -10,862.209 | -10,722.492 | -12,923.691 |
Inkomen voor belasting
| 47,960.768 | 36,464.134 | 17,922.517 | 7,739.375 | 11,969.484 | 28,590.92 | 20,674.313 | 17,247.53 | 16,773.739 | 10,248.874 | 15,442.641 | 13,263.773 | 6,116.342 | 2,256.028 | 16,588.842 |
Inkomen voor belasting ratio
| 0.014 | 0.011 | 0.006 | 0.003 | 0.004 | 0.012 | 0.01 | 0.009 | 0.01 | 0.007 | 0.012 | 0.011 | 0.006 | 0.003 | 0.016 |
Belastingkosten
| 14,879.566 | 12,000.079 | 8,351.281 | 4,935.044 | 4,089.476 | 9,146.658 | 6,493.968 | 6,141.698 | 4,866.541 | 2,930.337 | 5,195.351 | 3,415.548 | 2,114.827 | 748.619 | 7,076.702 |
Nettowinst
| 33,087.529 | 24,464.055 | 9,571.236 | 2,804.331 | 7,880.007 | 19,444.262 | 14,180.346 | 11,105.832 | 11,907.197 | 7,318.537 | 10,247.289 | 9,848.224 | 4,001.515 | 1,507.409 | 9,512.141 |
Nettowinstmarge
| 0.01 | 0.008 | 0.003 | 0.001 | 0.003 | 0.008 | 0.007 | 0.006 | 0.007 | 0.005 | 0.008 | 0.008 | 0.004 | 0.002 | 0.009 |
WPA (Winst Per Aandeel)
| 25.97 | 19.2 | 7.51 | 2.2 | 6.19 | 15.26 | 18.89 | 14.98 | 16.06 | 9.89 | 13.81 | 13.27 | 4.91 | 1.96 | 12.76 |
Verwaterde WPA
| 25.97 | 19.2 | 7.51 | 2.2 | 6.19 | 15.26 | 18.89 | 14.98 | 16.06 | 9.89 | 13.81 | 13.27 | 4.91 | 1.96 | 12.76 |
EBITDA
| 117,816.345 | 101,899.178 | 84,696.486 | 69,342.353 | 71,235.718 | 68,192.25 | 54,413.482 | 47,997.815 | 48,275.737 | 38,667.086 | 35,256.591 | 27,850.795 | 17,261.047 | 12,460.989 | 26,079.337 |
EBITDA ratio
| 0.035 | 0.032 | 0.028 | 0.026 | 0.026 | 0.029 | 0.026 | 0.024 | 0.028 | 0.027 | 0.027 | 0.024 | 0.018 | 0.015 | 0.026 |